GLP-1 Receptor Agonist Use and Sarcopenia in Obese Individuals Without Diabetes
GLP-1 Receptor Agonist Use and Sarcopenia in Obese Individuals Without Diabetes
Recruiting · NCT07858864 · Registry updated 2026-10-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| GLP-1 Receptor Agonist Use and Sarcopenia in Obese Individuals Without Diabetes | Atrophy, Body Weight, Neurologic Manifestations, Neuromuscular Manifestations, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Sarcopenia, Signs and Symptoms, muscular atrophy, nervous system disorder, nutritional disorder, obesity disorder, overnutrition | Recruiting | Not stated | 2026-10-08 | NCT07858864 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Istanbul Saglik Bilimleri University | 17 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Kanuni Sultan Süleyman Training and Research Hospital | Istanbul | Turkey (Türkiye) | 1 |